In the last 12 months, insiders at Cingulate Inc. ($CING) filed 107 transactions with the SEC: 15 open-market purchases totaling $1,177,873 and 1 sales totaling $841. Net insider sentiment: net buying.
Cingulate Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Werth Peter J. (Director) — 15 transactions totaling $1,098,807
- Schaffer Shane J. (Chief Executive Officer) — 10 transactions totaling $34,317
- Callahan Jennifer L. (SVP and CFO) — 9 transactions totaling $26,005
- Brams Matthew (EVP and Chief Medical Officer) — 14 transactions totaling $9,808
- Callahan Jennifer L. (Corporate Controller) — 5 transactions totaling $9,689
View all SEC Filings for Cingulate Inc. (CING).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Brams Matthew | EVP and Chief Medical Officer | A | Common Stock | 4526 | $0.00 | 9,182.0000 | 6,757,070 | 97.21% | 0.07% |
| March 9, 2026 | Brams Matthew | EVP and Chief Medical Officer | F | Common Stock | 1025 | $0.00 | 8,157.0000 | 6,757,070 | 11.16% | 0.02% |
| March 9, 2026 | Silva Raul R. | EVP and CSO | A | Common Stock | 4526 | $0.00 | 6,473.0000 | 6,757,070 | 232.46% | 0.07% |
| March 9, 2026 | Silva Raul R. | EVP and CSO | F | Common Stock | 1828 | $0.00 | 4,645.0000 | 6,757,070 | 28.24% | 0.03% |
| March 9, 2026 | Schaffer Shane J. | Chief Executive Officer | A | Common Stock | 6862 | $0.00 | 17,210.0000 | 6,757,070 | 66.31% | 0.10% |
| March 9, 2026 | Schaffer Shane J. | Chief Executive Officer | F | Common Stock | 2959 | $0.00 | 14,251.0000 | 6,757,070 | 17.19% | 0.04% |
| March 9, 2026 | Callahan Jennifer L. | EVP and CFO | A | Common Stock | 15329 | $0.00 | 20,388.0000 | 6,757,070 | 303.00% | 0.23% |
| March 9, 2026 | Callahan Jennifer L. | EVP and CFO | F | Common Stock | 6427 | $0.00 | 13,961.0000 | 6,757,070 | 31.52% | 0.10% |
| March 9, 2026 | Patel Nilay Dahyabhai | EVP, CLO and CCO | A | Common Stock | 5475 | $0.00 | 5,475.0000 | 6,757,070 | 9999.99% | 0.08% |
| March 9, 2026 | Patel Nilay Dahyabhai | EVP, CLO and CCO | F | Common Stock | 2086 | $0.00 | 3,389.0000 | 6,757,070 | 38.10% | 0.03% |
| Feb. 6, 2026 | Werth Peter J. | Director | P | Warrant to Purchase Common Stock | 15564 | $0.10 | 15,564.0000 | 6,757,070 | 9999.99% | 0.23% |
| Feb. 6, 2026 | Werth Peter J. | Director | P | Common Stock | 19455 | $5.04 | 117,541.0000 | 6,757,070 | 19.83% | 0.29% |
| Feb. 6, 2026 | Brams Matthew | EVP and Chief Medical Officer | P | Warrant to Purchase Common Stock | 1556 | $0.10 | 1,556.0000 | 6,757,070 | 9999.99% | 0.02% |
| Feb. 6, 2026 | Brams Matthew | EVP and Chief Medical Officer | P | Common Stock | 1946 | $5.04 | 4,656.0000 | 6,757,070 | 71.81% | 0.03% |
| Feb. 6, 2026 | Schaffer Shane J. | Chief Executive Officer | P | Warrant to Purchase Common Stock | 5447 | $0.10 | 5,447.0000 | 6,757,070 | 9999.99% | 0.08% |
| Feb. 6, 2026 | Schaffer Shane J. | Chief Executive Officer | P | Common Stock | 6809 | $5.04 | 10,348.0000 | 6,757,070 | 192.40% | 0.10% |
| Feb. 6, 2026 | Callahan Jennifer L. | SVP and CFO | P | Warrant to Purchase Common Stock | 3891 | $0.10 | 3,891.0000 | 6,757,070 | 9999.99% | 0.06% |
| Feb. 6, 2026 | Callahan Jennifer L. | SVP and CFO | P | Common Stock | 4864 | $5.04 | 5,059.0000 | 6,757,070 | 2494.36% | 0.07% |
| Dec. 31, 2025 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 6625 | $0.00 | 6,625.0000 | 6,757,070 | 9999.99% | 0.10% |
| Sept. 30, 2025 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 7334 | $0.00 | 7,334.0000 | 3,768,400 | 9999.99% | 0.19% |
| Nov. 3, 2025 | Downey Bryan Wade | Chief Commercial Officer | A | Stock Option (right to Buy) | 30000 | $0.00 | 30,000.0000 | 3,768,400 | 9999.99% | 0.80% |
| July 8, 2025 | Patel Nilay Dahyabhai | CLO and CCO | A | Stock Option (right to Buy) | 30000 | $0.00 | 30,000.0000 | 3,768,400 | 9999.99% | 0.80% |
| July 7, 2025 | Brams Matthew | EVP and Chief Medical Officer | A | Stock Option (right to Buy) | 52500 | $0.00 | 52,500.0000 | 3,768,400 | 9999.99% | 1.39% |
| July 7, 2025 | Schaffer Shane J. | Chief Executive Officer | A | Stock Option (right to Buy) | 199500 | $0.00 | 199,500.0000 | 3,768,400 | 9999.99% | 5.29% |
| July 7, 2025 | Callahan Jennifer L. | SVP and CFO | A | Stock Option (right to Buy) | 64500 | $0.00 | 64,500.0000 | 3,768,400 | 9999.99% | 1.71% |
| July 7, 2025 | Myers Laurie | EVP and COO | A | Stock Option (right to Buy) | 31000 | $0.00 | 31,000.0000 | 3,768,400 | 9999.99% | 0.82% |
| July 7, 2025 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 51500 | $0.00 | 51,500.0000 | 3,768,400 | 9999.99% | 1.37% |
| June 30, 2025 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 1000 | $0.00 | 1,000.0000 | 3,768,400 | 9999.99% | 0.03% |
| March 31, 2025 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 1000 | $0.00 | 1,000.0000 | 3,768,400 | 9999.99% | 0.03% |
| June 20, 2025 | Werth Peter J. | Director | A | Stock Option (right to Buy) | 15000 | $0.00 | 15,000.0000 | 3,768,400 | 9999.99% | 0.40% |
| June 20, 2025 | ROBERTS JOHN A | Director | A | Stock Option (right to Buy) | 15000 | $0.00 | 15,000.0000 | 3,768,400 | 9999.99% | 0.40% |
| June 20, 2025 | Ervin Jeffrey S | Director | A | Stock Option (right to Buy) | 15000 | $0.00 | 15,000.0000 | 3,768,400 | 9999.99% | 0.40% |
| June 20, 2025 | Lawrence Bryan Jay | Director | A | Stock Option (right to Buy) | 15000 | $0.00 | 15,000.0000 | 3,768,400 | 9999.99% | 0.40% |
| Feb. 18, 2025 | Myers Laurie | EVP and COO | A | Stock Option (right to Buy) | 17630 | $0.00 | 17,630.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2025 | Callahan Jennifer L. | SVP and CFO | A | Stock Option (right to Buy) | 21140 | $0.00 | 21,140.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2025 | Schaffer Shane J. | Chief Executive Officer | A | Stock Option (right to Buy) | 70489 | $0.00 | 70,489.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2025 | Brams Matthew | EVP and Chief Medical Officer | A | Stock Option (right to Buy) | 17630 | $0.00 | 17,630.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2025 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 17630 | $0.00 | 17,630.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2025 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 2748 | $0.00 | 2,748.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2025 | Callahan Jennifer L. | SVP and CFO | A | Stock Option (right to Buy) | 11539 | $0.00 | 11,539.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2025 | Brams Matthew | EVP and Chief Medical Officer | A | Stock Option (right to Buy) | 2748 | $0.00 | 2,748.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2025 | Schaffer Shane J. | Chief Executive Officer | A | Stock Option (right to Buy) | 27638 | $0.00 | 27,638.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2025 | Myers Laurie | EVP and COO | A | Stock Option (right to Buy) | 9319 | $0.00 | 9,319.0000 | 0 | 9999.99% | 0.00% |
| Dec. 31, 2024 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 1000 | $0.00 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 31, 2024 | Brams Matthew | EVP and Chief Medical Officer | A | Stock Option (right to Buy) | 1000 | $0.00 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2024 | Brams Matthew | EVP and Chief Medical Officer | A | Stock Option (right to Buy) | 1000 | $0.00 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2024 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 1000 | $0.00 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 15, 2024 | Myers Laurie | EVP and COO | S | Common Stock | 202 | $4.17 | 0.0000 | 0 | 100.00% | 0.00% |
| June 28, 2024 | Brams Matthew | EVP and Chief Medical Officer | A | Stock Option (right to Buy) | 1000 | $0.00 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| June 28, 2024 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 1000 | $0.00 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Werth Peter J. | Director | A | Stock Option (right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Brams Matthew | EVP and Chief Medical Officer | A | Stock Option (right to Buy) | 63324 | $0.00 | 63,324.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Schaffer Shane J. | Chief Executive Officer | A | Stock Option (right to Buy) | 217677 | $0.00 | 217,677.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Callahan Jennifer L. | SVP and CFO | A | Stock Option (right to Buy) | 94986 | $0.00 | 94,986.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Myers Laurie | EVP and COO | A | Stock Option (right to Buy) | 98944 | $0.00 | 98,944.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | ROBERTS JOHN A | Director | A | Stock Option (right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | ROBERTS JOHN A | Director | A | Stock Option (right to Buy) | 14750 | $0.00 | 14,750.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | ROBERTS JOHN A | Director | A | Stock Option (right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Lawrence Bryan Jay | Director | A | Stock Option (right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Lawrence Bryan Jay | Director | A | Stock Option (right to Buy) | 14125 | $0.00 | 14,125.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Lawrence Bryan Jay | Director | A | Stock Option (right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Ervin Jeffrey S | Director | A | Stock Option (right to Buy) | 13875 | $0.00 | 13,875.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Ervin Jeffrey S | Director | A | Stock Option (right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Ervin Jeffrey S | Director | A | Stock Option (right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 63324 | $0.00 | 63,324.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Werth Peter J. | Director | A | Stock Option (right to Buy) | 6926 | $0.00 | 6,926.0000 | 0 | 9999.99% | 0.00% |
| April 11, 2024 | Werth Peter J. | Director | M | Common Stock | 694096 | $0.00 | 1,177,018.0000 | 0 | 143.73% | 0.00% |
| April 11, 2024 | Werth Peter J. | Director | M | Common Stock | 341912 | $0.00 | 482,922.0000 | 0 | 242.47% | 0.00% |
| April 11, 2024 | Werth Peter J. | Director | M | Pre-Funded Warrant (right to buy) | 341912 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 11, 2024 | Werth Peter J. | Director | M | Pre-Funded Warrant (right to buy) | 694096 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 29, 2024 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 1000 | $0.00 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| March 29, 2024 | Brams Matthew | EVP and Chief Medical Officer | A | Stock Option (right to Buy) | 1000 | $0.00 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Werth Peter J. | Director | J | Pre-Funded Warrant (right to buy) | 7053 | $0.00 | 694,096.0000 | 0 | 1.03% | 0.00% |
| March 15, 2022 | Callahan Jennifer L. | SVP and CFO | P | Common Stock | 55 | $27.10 | 2,333.0000 | 0 | 2.41% | 0.00% |
| March 15, 2022 | Callahan Jennifer L. | SVP and CFO | P | Warrant to Purchase Common Stock | 1500 | $0.30 | 21,030.0000 | 0 | 7.68% | 0.00% |
| March 4, 2024 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 16676 | $0.00 | 16,676.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | Lawrence Bryan Jay | Director | A | Stock Option (right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | Brams Matthew | EVP and Chief Medical Officer | A | Stock Option (right to Buy) | 16676 | $0.00 | 16,676.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | Callahan Jennifer L. | SVP and CFO | A | Stock Option (right to Buy) | 25014 | $0.00 | 25,014.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | Myers Laurie | EVP and COO | A | Stock Option (right to Buy) | 26056 | $0.00 | 26,056.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | Schaffer Shane J. | Chief Executive Officer | A | Stock Option (right to Buy) | 57323 | $0.00 | 57,323.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | ROBERTS JOHN A | Director | A | Stock Option (right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | Werth Peter J. | Director | A | Stock Option (right to Buy) | 1824 | $0.00 | 1,824.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | Ervin Jeffrey S | Director | A | Stock Option (right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 25, 2024 | Werth Peter J. | Director | J | Pre-Funded Warrant (right to buy) | 687043 | $0.00 | 687,043.0000 | 0 | 9999.99% | 0.00% |
| Dec. 29, 2023 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 1000 | $0.00 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 29, 2023 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 15, 2023 | Callahan Jennifer L. | Corporate Controller | P | Common Stock | 5000 | $0.67 | 45,508.0000 | 0 | 12.34% | 0.00% |
| Sept. 8, 2023 | Werth Peter J. | Director | J | Pre-Funded Warrant (right to buy) | 6838235 | $0.00 | 6,838,235.0000 | 0 | 9999.99% | 0.00% |
| Aug. 11, 2023 | Werth Peter J. | Director | P | Common Stock | 1823155 | $0.55 | 2,820,169.0000 | 0 | 182.86% | 0.00% |
| June 30, 2023 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | GIVENS GREGG WM | Director | A | Stock Option (right to Buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Medeiros Curtis | Director | A | Stock Option (right to Buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Werth Peter J. | Director | A | Stock Option (right to Buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Applebaum Scott | Director | A | Stock Option (right to Buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Gallagher Patrick Joseph | Director | A | Stock Option (right to Buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2023 | Callahan Jennifer L. | Corporate Controller | P | Common Stock | 2000 | $1.01 | 40,508.0000 | 0 | 5.19% | 0.00% |
| May 12, 2023 | Callahan Jennifer L. | Corporate Controller | P | Common Stock | 4000 | $1.08 | 38,508.0000 | 0 | 11.59% | 0.00% |
| May 12, 2023 | Callahan Jennifer L. | Corporate Controller | P | Warrant to Purchase Common Stock | 1030 | $0.11 | 19,530.0000 | 0 | 5.57% | 0.00% |
| March 31, 2023 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Brams Matthew | EVP and Chief Medical Officer | A | Stock Option (right to Buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Callahan Jennifer L. | Corporate Controller | A | Stock Option (right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Gilgallon Craig S. | EVP and General Counsel | A | Stock Option (right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Myers Laurie | EVP and COO | A | Stock Option (right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Schaffer Shane J. | Chief Executive Officer | A | Stock Option (right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | VAN HORN LOUIS G | EVP and CFO | A | Stock Option (right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 30, 2022 | Silva Raul R. | EVP and CSO | A | Stock Option (right to Buy) | 16084 | $0.00 | 16,084.0000 | 0 | 9999.99% | 0.00% |